nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—CYP2C9—brain cancer	0.497	1	CbGaD
Cimetidine—CYP2D6—Lomustine—brain cancer	0.0477	0.164	CbGbCtD
Cimetidine—CYP1A2—Carmustine—brain cancer	0.0472	0.162	CbGbCtD
Cimetidine—CYP2D6—Hydroxyurea—brain cancer	0.0361	0.124	CbGbCtD
Cimetidine—CYP3A4—Temozolomide—brain cancer	0.0357	0.122	CbGbCtD
Cimetidine—CYP3A4—Lomustine—brain cancer	0.0303	0.104	CbGbCtD
Cimetidine—CYP2E1—Etoposide—brain cancer	0.0242	0.0829	CbGbCtD
Cimetidine—CYP3A5—Etoposide—brain cancer	0.0188	0.0644	CbGbCtD
Cimetidine—CYP2C8—Etoposide—brain cancer	0.0181	0.062	CbGbCtD
Cimetidine—CYP1A2—Etoposide—brain cancer	0.014	0.048	CbGbCtD
Cimetidine—ABCB1—Etoposide—brain cancer	0.0122	0.0419	CbGbCtD
Cimetidine—Hepatic insufficiency—Hydroxyurea—brain cancer	0.00851	0.0755	CcSEcCtD
Cimetidine—SLC22A8—choroid plexus—brain cancer	0.00733	0.175	CbGeAlD
Cimetidine—CYP3A4—Etoposide—brain cancer	0.00733	0.0251	CbGbCtD
Cimetidine—Necrolysis epidermal—Etoposide—brain cancer	0.00362	0.0322	CcSEcCtD
Cimetidine—Alopecia reversible—Etoposide—brain cancer	0.00362	0.0322	CcSEcCtD
Cimetidine—Hepatotoxicity—Lomustine—brain cancer	0.00347	0.0308	CcSEcCtD
Cimetidine—Traumatic liver injury—Temozolomide—brain cancer	0.00276	0.0245	CcSEcCtD
Cimetidine—Disorientation—Lomustine—brain cancer	0.00217	0.0193	CcSEcCtD
Cimetidine—Bone marrow depression—Hydroxyurea—brain cancer	0.00195	0.0173	CcSEcCtD
Cimetidine—Hepatotoxicity—Hydroxyurea—brain cancer	0.0017	0.0151	CcSEcCtD
Cimetidine—Pancytopenia—Lomustine—brain cancer	0.0016	0.0142	CcSEcCtD
Cimetidine—Gynaecomastia—Procarbazine—brain cancer	0.00152	0.0135	CcSEcCtD
Cimetidine—Renal failure—Lomustine—brain cancer	0.00147	0.0131	CcSEcCtD
Cimetidine—SLC22A1—ganglion—brain cancer	0.00145	0.0346	CbGeAlD
Cimetidine—Disorientation—Procarbazine—brain cancer	0.00138	0.0122	CcSEcCtD
Cimetidine—Hepatotoxicity—Carmustine—brain cancer	0.00138	0.0122	CcSEcCtD
Cimetidine—Hepatotoxicity—Temozolomide—brain cancer	0.00133	0.0118	CcSEcCtD
Cimetidine—SLC47A1—hindbrain—brain cancer	0.00132	0.0315	CbGeAlD
Cimetidine—Liver injury—Temozolomide—brain cancer	0.00122	0.0108	CcSEcCtD
Cimetidine—Alopecia—Lomustine—brain cancer	0.00119	0.0105	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00111	0.00986	CcSEcCtD
Cimetidine—Disorientation—Hydroxyurea—brain cancer	0.00107	0.00948	CcSEcCtD
Cimetidine—Hepatotoxicity—Etoposide—brain cancer	0.00107	0.00945	CcSEcCtD
Cimetidine—Hepatic failure—Hydroxyurea—brain cancer	0.00106	0.00943	CcSEcCtD
Cimetidine—Leukopenia—Lomustine—brain cancer	0.00105	0.0093	CcSEcCtD
Cimetidine—Pancreatitis—Procarbazine—brain cancer	0.00105	0.00928	CcSEcCtD
Cimetidine—Musculoskeletal pain—Temozolomide—brain cancer	0.00104	0.00923	CcSEcCtD
Cimetidine—Pancytopenia—Procarbazine—brain cancer	0.00101	0.00899	CcSEcCtD
Cimetidine—Aplastic anaemia—Temozolomide—brain cancer	0.000965	0.00856	CcSEcCtD
Cimetidine—Pneumonia—Procarbazine—brain cancer	0.000957	0.00849	CcSEcCtD
Cimetidine—Gynaecomastia—Carmustine—brain cancer	0.000952	0.00845	CcSEcCtD
Cimetidine—Drowsiness—Procarbazine—brain cancer	0.000951	0.00844	CcSEcCtD
Cimetidine—Thrombocytopenia—Lomustine—brain cancer	0.000935	0.0083	CcSEcCtD
Cimetidine—FMO1—pituitary gland—brain cancer	0.000921	0.022	CbGeAlD
Cimetidine—CYP11B1—endocrine gland—brain cancer	0.0009	0.0215	CbGeAlD
Cimetidine—Blood creatinine increased—Hydroxyurea—brain cancer	0.000895	0.00794	CcSEcCtD
Cimetidine—Body temperature increased—Carboplatin—brain cancer	0.000863	0.00766	CcSEcCtD
Cimetidine—Hallucination—Procarbazine—brain cancer	0.000849	0.00754	CcSEcCtD
Cimetidine—Hepatic failure—Temozolomide—brain cancer	0.00083	0.00737	CcSEcCtD
Cimetidine—Pancreatitis—Hydroxyurea—brain cancer	0.000809	0.00718	CcSEcCtD
Cimetidine—FMO3—pituitary gland—brain cancer	0.000796	0.019	CbGeAlD
Cimetidine—Dermatitis exfoliative—Temozolomide—brain cancer	0.000791	0.00702	CcSEcCtD
Cimetidine—Pancytopenia—Hydroxyurea—brain cancer	0.000784	0.00696	CcSEcCtD
Cimetidine—Neutropenia—Hydroxyurea—brain cancer	0.000772	0.00685	CcSEcCtD
Cimetidine—SLC47A1—brainstem—brain cancer	0.000757	0.018	CbGeAlD
Cimetidine—Body temperature increased—Lomustine—brain cancer	0.000755	0.0067	CcSEcCtD
Cimetidine—Alopecia—Procarbazine—brain cancer	0.000754	0.0067	CcSEcCtD
Cimetidine—Drowsiness—Hydroxyurea—brain cancer	0.000736	0.00653	CcSEcCtD
Cimetidine—FMO1—endocrine gland—brain cancer	0.000714	0.017	CbGeAlD
Cimetidine—FMO1—head—brain cancer	0.000705	0.0168	CbGeAlD
Cimetidine—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000672	0.00596	CcSEcCtD
Cimetidine—Leukopenia—Procarbazine—brain cancer	0.000665	0.0059	CcSEcCtD
Cimetidine—Hallucination—Hydroxyurea—brain cancer	0.000657	0.00583	CcSEcCtD
Cimetidine—FMO1—central nervous system—brain cancer	0.000643	0.0153	CbGeAlD
Cimetidine—Pancytopenia—Carmustine—brain cancer	0.000634	0.00562	CcSEcCtD
Cimetidine—Myalgia—Procarbazine—brain cancer	0.000633	0.00562	CcSEcCtD
Cimetidine—Arthralgia—Procarbazine—brain cancer	0.000633	0.00562	CcSEcCtD
Cimetidine—Anxiety—Procarbazine—brain cancer	0.000631	0.0056	CcSEcCtD
Cimetidine—Neutropenia—Carmustine—brain cancer	0.000624	0.00554	CcSEcCtD
Cimetidine—ABCB11—endocrine gland—brain cancer	0.000624	0.0149	CbGeAlD
Cimetidine—FMO3—endocrine gland—brain cancer	0.000617	0.0147	CbGeAlD
Cimetidine—Pancytopenia—Temozolomide—brain cancer	0.000612	0.00544	CcSEcCtD
Cimetidine—Confusional state—Procarbazine—brain cancer	0.000612	0.00543	CcSEcCtD
Cimetidine—CYP3A7—endocrine gland—brain cancer	0.00061	0.0145	CbGeAlD
Cimetidine—FMO3—head—brain cancer	0.000609	0.0145	CbGeAlD
Cimetidine—Vomiting—Lomustine—brain cancer	0.000607	0.00539	CcSEcCtD
Cimetidine—Neutropenia—Temozolomide—brain cancer	0.000603	0.00535	CcSEcCtD
Cimetidine—Pneumonia—Carmustine—brain cancer	0.000598	0.00531	CcSEcCtD
Cimetidine—Erectile dysfunction—Temozolomide—brain cancer	0.000594	0.00527	CcSEcCtD
Cimetidine—Thrombocytopenia—Procarbazine—brain cancer	0.000594	0.00527	CcSEcCtD
Cimetidine—Tachycardia—Procarbazine—brain cancer	0.000592	0.00525	CcSEcCtD
Cimetidine—Renal failure—Carmustine—brain cancer	0.000585	0.00519	CcSEcCtD
Cimetidine—Alopecia—Hydroxyurea—brain cancer	0.000584	0.00518	CcSEcCtD
Cimetidine—Pneumonia—Temozolomide—brain cancer	0.000578	0.00513	CcSEcCtD
Cimetidine—SLC22A11—endocrine gland—brain cancer	0.000576	0.0137	CbGeAlD
Cimetidine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.00057	0.00506	CcSEcCtD
Cimetidine—Nausea—Lomustine—brain cancer	0.000567	0.00504	CcSEcCtD
Cimetidine—SLC22A7—endocrine gland—brain cancer	0.000563	0.0134	CbGeAlD
Cimetidine—SLC47A1—gonad—brain cancer	0.000561	0.0134	CbGeAlD
Cimetidine—SLC22A1—telencephalon—brain cancer	0.000561	0.0134	CbGeAlD
Cimetidine—FMO3—central nervous system—brain cancer	0.000556	0.0132	CbGeAlD
Cimetidine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000553	0.0049	CcSEcCtD
Cimetidine—HRH2—endocrine gland—brain cancer	0.000549	0.0131	CbGeAlD
Cimetidine—SLC47A1—pituitary gland—brain cancer	0.000547	0.013	CbGeAlD
Cimetidine—HRH2—head—brain cancer	0.000542	0.0129	CbGeAlD
Cimetidine—Somnolence—Procarbazine—brain cancer	0.000539	0.00479	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000538	0.00477	CcSEcCtD
Cimetidine—Hallucination—Carmustine—brain cancer	0.000531	0.00472	CcSEcCtD
Cimetidine—SLC47A1—medulla oblongata—brain cancer	0.000528	0.0126	CbGeAlD
Cimetidine—Fatigue—Procarbazine—brain cancer	0.000523	0.00464	CcSEcCtD
Cimetidine—Malaise—Hydroxyurea—brain cancer	0.000519	0.0046	CcSEcCtD
Cimetidine—Constipation—Procarbazine—brain cancer	0.000519	0.0046	CcSEcCtD
Cimetidine—Hepatitis—Temozolomide—brain cancer	0.000516	0.00458	CcSEcCtD
Cimetidine—Leukopenia—Hydroxyurea—brain cancer	0.000515	0.00457	CcSEcCtD
Cimetidine—Hallucination—Temozolomide—brain cancer	0.000514	0.00456	CcSEcCtD
Cimetidine—FMO1—brain—brain cancer	0.000511	0.0122	CbGeAlD
Cimetidine—Feeling abnormal—Procarbazine—brain cancer	0.0005	0.00444	CcSEcCtD
Cimetidine—HRH2—central nervous system—brain cancer	0.000495	0.0118	CbGeAlD
Cimetidine—CYP2D6—hindbrain—brain cancer	0.000494	0.0118	CbGeAlD
Cimetidine—Pancytopenia—Etoposide—brain cancer	0.00049	0.00435	CcSEcCtD
Cimetidine—Erythema multiforme—Temozolomide—brain cancer	0.000488	0.00433	CcSEcCtD
Cimetidine—Neutropenia—Etoposide—brain cancer	0.000483	0.00428	CcSEcCtD
Cimetidine—Body temperature increased—Procarbazine—brain cancer	0.000479	0.00426	CcSEcCtD
Cimetidine—SLC22A4—pituitary gland—brain cancer	0.000479	0.0114	CbGeAlD
Cimetidine—Alopecia—Carmustine—brain cancer	0.000472	0.00419	CcSEcCtD
Cimetidine—SLC47A1—spinal cord—brain cancer	0.000471	0.0112	CbGeAlD
Cimetidine—Pneumonia—Etoposide—brain cancer	0.000463	0.00411	CcSEcCtD
Cimetidine—Thrombocytopenia—Hydroxyurea—brain cancer	0.00046	0.00408	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000456	0.00405	CcSEcCtD
Cimetidine—Alopecia—Temozolomide—brain cancer	0.000456	0.00405	CcSEcCtD
Cimetidine—Renal failure—Etoposide—brain cancer	0.000452	0.00401	CcSEcCtD
Cimetidine—SLC22A3—gonad—brain cancer	0.000447	0.0107	CbGeAlD
Cimetidine—Hypersensitivity—Procarbazine—brain cancer	0.000447	0.00397	CcSEcCtD
Cimetidine—FMO3—brain—brain cancer	0.000441	0.0105	CbGeAlD
Cimetidine—Asthenia—Procarbazine—brain cancer	0.000435	0.00386	CcSEcCtD
Cimetidine—Agranulocytosis—Etoposide—brain cancer	0.000429	0.00381	CcSEcCtD
Cimetidine—Agitation—Carmustine—brain cancer	0.000427	0.00379	CcSEcCtD
Cimetidine—SLC47A1—endocrine gland—brain cancer	0.000424	0.0101	CbGeAlD
Cimetidine—SLC47A1—head—brain cancer	0.000418	0.00997	CbGeAlD
Cimetidine—Somnolence—Hydroxyurea—brain cancer	0.000417	0.0037	CcSEcCtD
Cimetidine—Leukopenia—Carmustine—brain cancer	0.000416	0.00369	CcSEcCtD
Cimetidine—Diarrhoea—Procarbazine—brain cancer	0.000415	0.00368	CcSEcCtD
Cimetidine—Agitation—Temozolomide—brain cancer	0.000413	0.00366	CcSEcCtD
Cimetidine—SLC22A4—spinal cord—brain cancer	0.000413	0.00983	CbGeAlD
Cimetidine—Malaise—Temozolomide—brain cancer	0.000405	0.0036	CcSEcCtD
Cimetidine—Fatigue—Hydroxyurea—brain cancer	0.000405	0.00359	CcSEcCtD
Cimetidine—SLC22A7—brain—brain cancer	0.000402	0.00959	CbGeAlD
Cimetidine—Leukopenia—Temozolomide—brain cancer	0.000402	0.00357	CcSEcCtD
Cimetidine—Constipation—Hydroxyurea—brain cancer	0.000401	0.00356	CcSEcCtD
Cimetidine—Dizziness—Procarbazine—brain cancer	0.000401	0.00356	CcSEcCtD
Cimetidine—Myalgia—Carmustine—brain cancer	0.000396	0.00351	CcSEcCtD
Cimetidine—Anxiety—Carmustine—brain cancer	0.000394	0.0035	CcSEcCtD
Cimetidine—HRH2—brain—brain cancer	0.000393	0.00936	CbGeAlD
Cimetidine—Erythema multiforme—Etoposide—brain cancer	0.000391	0.00347	CcSEcCtD
Cimetidine—SLC22A6—brain—brain cancer	0.000389	0.00926	CbGeAlD
Cimetidine—Feeling abnormal—Hydroxyurea—brain cancer	0.000387	0.00343	CcSEcCtD
Cimetidine—Vomiting—Procarbazine—brain cancer	0.000386	0.00342	CcSEcCtD
Cimetidine—Confusional state—Carmustine—brain cancer	0.000383	0.0034	CcSEcCtD
Cimetidine—Arthralgia—Temozolomide—brain cancer	0.000383	0.0034	CcSEcCtD
Cimetidine—Myalgia—Temozolomide—brain cancer	0.000383	0.0034	CcSEcCtD
Cimetidine—Rash—Procarbazine—brain cancer	0.000382	0.00339	CcSEcCtD
Cimetidine—Dermatitis—Procarbazine—brain cancer	0.000382	0.00339	CcSEcCtD
Cimetidine—SLC47A1—central nervous system—brain cancer	0.000382	0.0091	CbGeAlD
Cimetidine—Anxiety—Temozolomide—brain cancer	0.000381	0.00338	CcSEcCtD
Cimetidine—Headache—Procarbazine—brain cancer	0.00038	0.00337	CcSEcCtD
Cimetidine—SLC47A1—cerebellum—brain cancer	0.000373	0.0089	CbGeAlD
Cimetidine—ABCB1—blood vessel—brain cancer	0.000373	0.00889	CbGeAlD
Cimetidine—Thrombocytopenia—Carmustine—brain cancer	0.000372	0.0033	CcSEcCtD
Cimetidine—Body temperature increased—Hydroxyurea—brain cancer	0.000371	0.00329	CcSEcCtD
Cimetidine—Tachycardia—Carmustine—brain cancer	0.00037	0.00329	CcSEcCtD
Cimetidine—Confusional state—Temozolomide—brain cancer	0.00037	0.00328	CcSEcCtD
Cimetidine—Anaphylactic shock—Temozolomide—brain cancer	0.000367	0.00325	CcSEcCtD
Cimetidine—Alopecia—Etoposide—brain cancer	0.000365	0.00324	CcSEcCtD
Cimetidine—Nausea—Procarbazine—brain cancer	0.00036	0.0032	CcSEcCtD
Cimetidine—Thrombocytopenia—Temozolomide—brain cancer	0.000359	0.00319	CcSEcCtD
Cimetidine—SLC22A1—endocrine gland—brain cancer	0.000354	0.00843	CbGeAlD
Cimetidine—SLC22A1—head—brain cancer	0.000349	0.00832	CbGeAlD
Cimetidine—Hypersensitivity—Hydroxyurea—brain cancer	0.000346	0.00307	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000346	0.00307	CcSEcCtD
Cimetidine—SLC22A3—endocrine gland—brain cancer	0.000338	0.00806	CbGeAlD
Cimetidine—Somnolence—Carmustine—brain cancer	0.000337	0.00299	CcSEcCtD
Cimetidine—Asthenia—Hydroxyurea—brain cancer	0.000337	0.00299	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000334	0.00297	CcSEcCtD
Cimetidine—SLC22A3—head—brain cancer	0.000334	0.00795	CbGeAlD
Cimetidine—SLC22A4—cerebellum—brain cancer	0.000327	0.0078	CbGeAlD
Cimetidine—Somnolence—Temozolomide—brain cancer	0.000326	0.00289	CcSEcCtD
Cimetidine—Constipation—Carmustine—brain cancer	0.000325	0.00288	CcSEcCtD
Cimetidine—Malaise—Etoposide—brain cancer	0.000324	0.00288	CcSEcCtD
Cimetidine—Leukopenia—Etoposide—brain cancer	0.000322	0.00286	CcSEcCtD
Cimetidine—Diarrhoea—Hydroxyurea—brain cancer	0.000321	0.00285	CcSEcCtD
Cimetidine—SLC22A8—head—brain cancer	0.000321	0.00765	CbGeAlD
Cimetidine—SLC22A1—central nervous system—brain cancer	0.000319	0.0076	CbGeAlD
Cimetidine—CYP2E1—telencephalon—brain cancer	0.000318	0.00757	CbGeAlD
Cimetidine—SLC22A5—pituitary gland—brain cancer	0.000317	0.00756	CbGeAlD
Cimetidine—Fatigue—Temozolomide—brain cancer	0.000316	0.00281	CcSEcCtD
Cimetidine—Constipation—Temozolomide—brain cancer	0.000314	0.00278	CcSEcCtD
Cimetidine—Feeling abnormal—Carmustine—brain cancer	0.000313	0.00278	CcSEcCtD
Cimetidine—Dizziness—Hydroxyurea—brain cancer	0.00031	0.00275	CcSEcCtD
Cimetidine—CYP2C8—pituitary gland—brain cancer	0.000307	0.00732	CbGeAlD
Cimetidine—SLC22A5—medulla oblongata—brain cancer	0.000306	0.0073	CbGeAlD
Cimetidine—SLC22A3—central nervous system—brain cancer	0.000305	0.00726	CbGeAlD
Cimetidine—SLC47A1—brain—brain cancer	0.000303	0.00723	CbGeAlD
Cimetidine—Feeling abnormal—Temozolomide—brain cancer	0.000302	0.00268	CcSEcCtD
Cimetidine—Body temperature increased—Carmustine—brain cancer	0.0003	0.00266	CcSEcCtD
Cimetidine—Vomiting—Hydroxyurea—brain cancer	0.000298	0.00265	CcSEcCtD
Cimetidine—Rash—Hydroxyurea—brain cancer	0.000296	0.00263	CcSEcCtD
Cimetidine—Confusional state—Etoposide—brain cancer	0.000296	0.00263	CcSEcCtD
Cimetidine—Dermatitis—Hydroxyurea—brain cancer	0.000296	0.00262	CcSEcCtD
Cimetidine—Headache—Hydroxyurea—brain cancer	0.000294	0.00261	CcSEcCtD
Cimetidine—Anaphylactic shock—Etoposide—brain cancer	0.000293	0.0026	CcSEcCtD
Cimetidine—SLC22A8—central nervous system—brain cancer	0.000293	0.00698	CbGeAlD
Cimetidine—Body temperature increased—Temozolomide—brain cancer	0.00029	0.00257	CcSEcCtD
Cimetidine—Thrombocytopenia—Etoposide—brain cancer	0.000287	0.00255	CcSEcCtD
Cimetidine—Tachycardia—Etoposide—brain cancer	0.000286	0.00254	CcSEcCtD
Cimetidine—CYP2D6—brainstem—brain cancer	0.000283	0.00675	CbGeAlD
Cimetidine—SLC22A5—midbrain—brain cancer	0.00028	0.00667	CbGeAlD
Cimetidine—Hypersensitivity—Carmustine—brain cancer	0.00028	0.00248	CcSEcCtD
Cimetidine—Nausea—Hydroxyurea—brain cancer	0.000279	0.00247	CcSEcCtD
Cimetidine—SLC22A5—spinal cord—brain cancer	0.000273	0.00651	CbGeAlD
Cimetidine—CYP2C19—endocrine gland—brain cancer	0.000273	0.0065	CbGeAlD
Cimetidine—Asthenia—Carmustine—brain cancer	0.000272	0.00242	CcSEcCtD
Cimetidine—Hypersensitivity—Temozolomide—brain cancer	0.00027	0.0024	CcSEcCtD
Cimetidine—SLC22A4—brain—brain cancer	0.000266	0.00633	CbGeAlD
Cimetidine—Asthenia—Temozolomide—brain cancer	0.000263	0.00234	CcSEcCtD
Cimetidine—Somnolence—Etoposide—brain cancer	0.000261	0.00232	CcSEcCtD
Cimetidine—Diarrhoea—Carmustine—brain cancer	0.00026	0.0023	CcSEcCtD
Cimetidine—SLC22A1—brain—brain cancer	0.000253	0.00603	CbGeAlD
Cimetidine—Fatigue—Etoposide—brain cancer	0.000253	0.00225	CcSEcCtD
Cimetidine—CYP2D6—telencephalon—brain cancer	0.000251	0.00599	CbGeAlD
Cimetidine—Dizziness—Carmustine—brain cancer	0.000251	0.00223	CcSEcCtD
Cimetidine—Constipation—Etoposide—brain cancer	0.000251	0.00223	CcSEcCtD
Cimetidine—Diarrhoea—Temozolomide—brain cancer	0.000251	0.00223	CcSEcCtD
Cimetidine—CYP2E1—medulla oblongata—brain cancer	0.00025	0.00595	CbGeAlD
Cimetidine—Dizziness—Temozolomide—brain cancer	0.000243	0.00215	CcSEcCtD
Cimetidine—SLC22A3—brain—brain cancer	0.000242	0.00576	CbGeAlD
Cimetidine—Feeling abnormal—Etoposide—brain cancer	0.000242	0.00215	CcSEcCtD
Cimetidine—Vomiting—Carmustine—brain cancer	0.000241	0.00214	CcSEcCtD
Cimetidine—Rash—Carmustine—brain cancer	0.000239	0.00212	CcSEcCtD
Cimetidine—Dermatitis—Carmustine—brain cancer	0.000239	0.00212	CcSEcCtD
Cimetidine—CYP2C8—endocrine gland—brain cancer	0.000238	0.00567	CbGeAlD
Cimetidine—Headache—Carmustine—brain cancer	0.000238	0.00211	CcSEcCtD
Cimetidine—Vomiting—Temozolomide—brain cancer	0.000233	0.00207	CcSEcCtD
Cimetidine—SLC22A8—brain—brain cancer	0.000233	0.00554	CbGeAlD
Cimetidine—Body temperature increased—Etoposide—brain cancer	0.000232	0.00206	CcSEcCtD
Cimetidine—Rash—Temozolomide—brain cancer	0.000231	0.00205	CcSEcCtD
Cimetidine—Dermatitis—Temozolomide—brain cancer	0.000231	0.00205	CcSEcCtD
Cimetidine—Headache—Temozolomide—brain cancer	0.00023	0.00204	CcSEcCtD
Cimetidine—Nausea—Carmustine—brain cancer	0.000225	0.002	CcSEcCtD
Cimetidine—CYP1A2—endocrine gland—brain cancer	0.000223	0.00531	CbGeAlD
Cimetidine—CYP2E1—spinal cord—brain cancer	0.000222	0.0053	CbGeAlD
Cimetidine—Nausea—Temozolomide—brain cancer	0.000218	0.00193	CcSEcCtD
Cimetidine—SLC22A5—cerebellum—brain cancer	0.000216	0.00516	CbGeAlD
Cimetidine—Hypersensitivity—Etoposide—brain cancer	0.000216	0.00192	CcSEcCtD
Cimetidine—CYP3A5—endocrine gland—brain cancer	0.000215	0.00512	CbGeAlD
Cimetidine—CYP2C9—endocrine gland—brain cancer	0.000211	0.00504	CbGeAlD
Cimetidine—Asthenia—Etoposide—brain cancer	0.000211	0.00187	CcSEcCtD
Cimetidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00021	0.0037	CbGpPWpGaD
Cimetidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000207	0.00366	CbGpPWpGaD
Cimetidine—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000207	0.00365	CbGpPWpGaD
Cimetidine—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000206	0.00363	CbGpPWpGaD
Cimetidine—Diarrhoea—Etoposide—brain cancer	0.000201	0.00178	CcSEcCtD
Cimetidine—CYP2E1—endocrine gland—brain cancer	0.0002	0.00477	CbGeAlD
Cimetidine—CYP2E1—head—brain cancer	0.000198	0.00471	CbGeAlD
Cimetidine—Dizziness—Etoposide—brain cancer	0.000194	0.00172	CcSEcCtD
Cimetidine—Vomiting—Etoposide—brain cancer	0.000187	0.00166	CcSEcCtD
Cimetidine—Rash—Etoposide—brain cancer	0.000185	0.00164	CcSEcCtD
Cimetidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000185	0.00326	CbGpPWpGaD
Cimetidine—Dermatitis—Etoposide—brain cancer	0.000185	0.00164	CcSEcCtD
Cimetidine—Headache—Etoposide—brain cancer	0.000184	0.00163	CcSEcCtD
Cimetidine—ABCB1—telencephalon—brain cancer	0.000181	0.00431	CbGeAlD
Cimetidine—CYP2E1—central nervous system—brain cancer	0.00018	0.0043	CbGeAlD
Cimetidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000178	0.00314	CbGpPWpGaD
Cimetidine—CYP2E1—cerebellum—brain cancer	0.000176	0.0042	CbGeAlD
Cimetidine—SLC22A5—brain—brain cancer	0.000176	0.00419	CbGeAlD
Cimetidine—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000176	0.0031	CbGpPWpGaD
Cimetidine—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000175	0.0031	CbGpPWpGaD
Cimetidine—Nausea—Etoposide—brain cancer	0.000174	0.00155	CcSEcCtD
Cimetidine—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000173	0.00306	CbGpPWpGaD
Cimetidine—CYP2C8—brain—brain cancer	0.00017	0.00406	CbGeAlD
Cimetidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00017	0.003	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—HES1—brain cancer	0.000169	0.00298	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—PTCH2—brain cancer	0.000164	0.0029	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000163	0.00289	CbGpPWpGaD
Cimetidine—CYP3A4—endocrine gland—brain cancer	0.000161	0.00384	CbGeAlD
Cimetidine—CYP2D6—endocrine gland—brain cancer	0.000159	0.00378	CbGeAlD
Cimetidine—CYP2D6—head—brain cancer	0.000157	0.00373	CbGeAlD
Cimetidine—ABCB1—gonad—brain cancer	0.000151	0.0036	CbGeAlD
Cimetidine—ABCB1—pituitary gland—brain cancer	0.000147	0.00351	CbGeAlD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—S100A10—brain cancer	0.000146	0.00257	CbGpPWpGaD
Cimetidine—CYP3A4—central nervous system—brain cancer	0.000145	0.00346	CbGeAlD
Cimetidine—HRH2—GPCR downstream signaling—OR14C36—brain cancer	0.000144	0.00255	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—OR4C12—brain cancer	0.000144	0.00255	CbGpPWpGaD
Cimetidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000144	0.00254	CbGpPWpGaD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000143	0.00253	CbGpPWpGaD
Cimetidine—CYP2E1—brain—brain cancer	0.000143	0.00342	CbGeAlD
Cimetidine—CYP2D6—central nervous system—brain cancer	0.000143	0.00341	CbGeAlD
Cimetidine—ABCB1—medulla oblongata—brain cancer	0.000142	0.00339	CbGeAlD
Cimetidine—CYP2D6—cerebellum—brain cancer	0.00014	0.00333	CbGeAlD
Cimetidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000137	0.00242	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000137	0.00242	CbGpPWpGaD
Cimetidine—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000135	0.00239	CbGpPWpGaD
Cimetidine—SLC22A7—Fluoropyrimidine Activity—TP53—brain cancer	0.000135	0.00238	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—S100A10—brain cancer	0.000132	0.00233	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—OR4C12—brain cancer	0.000131	0.00231	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—OR14C36—brain cancer	0.000131	0.00231	CbGpPWpGaD
Cimetidine—ABCB1—midbrain—brain cancer	0.00013	0.0031	CbGeAlD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000128	0.00226	CbGpPWpGaD
Cimetidine—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000127	0.00225	CbGpPWpGaD
Cimetidine—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000127	0.00224	CbGpPWpGaD
Cimetidine—ABCB1—spinal cord—brain cancer	0.000127	0.00302	CbGeAlD
Cimetidine—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00222	CbGpPWpGaD
Cimetidine—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000125	0.00221	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000123	0.00218	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000123	0.00217	CbGpPWpGaD
Cimetidine—CYP11B1—Corticotropin-releasing hormone—RELA—brain cancer	0.000122	0.00215	CbGpPWpGaD
Cimetidine—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000116	0.00206	CbGpPWpGaD
Cimetidine—ABCB1—endocrine gland—brain cancer	0.000114	0.00272	CbGeAlD
Cimetidine—CYP2D6—brain—brain cancer	0.000113	0.0027	CbGeAlD
Cimetidine—ABCB1—head—brain cancer	0.000113	0.00268	CbGeAlD
Cimetidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000111	0.00196	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000111	0.00196	CbGpPWpGaD
Cimetidine—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00011	0.00194	CbGpPWpGaD
Cimetidine—CYP11B1—Corticotropin-releasing hormone—IL2—brain cancer	0.00011	0.00194	CbGpPWpGaD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000109	0.00192	CbGpPWpGaD
Cimetidine—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000109	0.00192	CbGpPWpGaD
Cimetidine—CYP11B1—Corticotropin-releasing hormone—CTNNB1—brain cancer	0.000106	0.00187	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—CYP2C9—brain cancer	0.000104	0.00183	CbGpPWpGaD
Cimetidine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000103	0.00182	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000103	0.00182	CbGpPWpGaD
Cimetidine—ABCB1—central nervous system—brain cancer	0.000103	0.00245	CbGeAlD
Cimetidine—ABCB1—cerebellum—brain cancer	0.0001	0.00239	CbGeAlD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.0001	0.00177	CbGpPWpGaD
Cimetidine—CYP2C19—Biological oxidations—CYP2C9—brain cancer	9.82e-05	0.00173	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	9.69e-05	0.00171	CbGpPWpGaD
Cimetidine—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.48e-05	0.00167	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	9.27e-05	0.00164	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.03e-05	0.00159	CbGpPWpGaD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	8.95e-05	0.00158	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.91e-05	0.00157	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—BSG—brain cancer	8.83e-05	0.00156	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—SHH—brain cancer	8.47e-05	0.0015	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.46e-05	0.00149	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PTCH2—brain cancer	8.44e-05	0.00149	CbGpPWpGaD
Cimetidine—ABCB1—brain—brain cancer	8.16e-05	0.00195	CbGeAlD
Cimetidine—HRH2—GPCR ligand binding—SMO—brain cancer	8.03e-05	0.00142	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—PTCH1—brain cancer	8.03e-05	0.00142	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.89e-05	0.00139	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—OR4C12—brain cancer	7.73e-05	0.00137	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—OR14C36—brain cancer	7.73e-05	0.00137	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	7.73e-05	0.00137	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.65e-05	0.00135	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—IDH1—brain cancer	7.59e-05	0.00134	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	7.55e-05	0.00133	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.55e-05	0.00133	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—IDH1—brain cancer	7.53e-05	0.00133	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.44e-05	0.00131	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CYP2C9—brain cancer	7.42e-05	0.00131	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—ABR—brain cancer	7.29e-05	0.00129	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	7.21e-05	0.00127	CbGpPWpGaD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—TRPC6—brain cancer	6.73e-05	0.00119	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—ABR—brain cancer	6.62e-05	0.00117	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DTX2—brain cancer	6.58e-05	0.00116	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—BSG—brain cancer	6.31e-05	0.00111	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.11e-05	0.00108	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CYP2C9—brain cancer	6.11e-05	0.00108	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—TRPC6—brain cancer	6.11e-05	0.00108	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—ENO2—brain cancer	6e-05	0.00106	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.91e-05	0.00104	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.82e-05	0.00103	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—TRPC6—brain cancer	5.69e-05	0.00101	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	5.67e-05	0.001	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—IDH1—brain cancer	5.43e-05	0.000958	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—BSG—brain cancer	5.19e-05	0.000917	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—TRPC6—brain cancer	5.13e-05	0.000906	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.09e-05	0.000899	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTCH2—brain cancer	4.98e-05	0.00088	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	4.83e-05	0.000853	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HES5—brain cancer	4.83e-05	0.000852	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CYP2C9—brain cancer	4.78e-05	0.000845	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STRADA—brain cancer	4.69e-05	0.000827	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—TRPC6—brain cancer	4.62e-05	0.000815	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CYP2C9—brain cancer	4.59e-05	0.00081	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.55e-05	0.000804	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—IDH1—brain cancer	4.47e-05	0.000788	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—SHH—brain cancer	4.35e-05	0.000767	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—ENO2—brain cancer	4.29e-05	0.000758	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	4.28e-05	0.000756	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.23e-05	0.000746	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.22e-05	0.000746	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—TRPC6—brain cancer	4.19e-05	0.00074	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PTCH1—brain cancer	4.12e-05	0.000727	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—SMO—brain cancer	4.12e-05	0.000727	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.1e-05	0.000724	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.08e-05	0.00072	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—BSG—brain cancer	4.07e-05	0.000718	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ABR—brain cancer	3.91e-05	0.00069	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—BSG—brain cancer	3.9e-05	0.000689	CbGpPWpGaD
Cimetidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.82e-05	0.000674	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GLI2—brain cancer	3.78e-05	0.000667	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.77e-05	0.000666	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.64e-05	0.000642	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.57e-05	0.00063	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GLI1—brain cancer	3.55e-05	0.000627	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—ENO2—brain cancer	3.53e-05	0.000623	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—IDH1—brain cancer	3.5e-05	0.000618	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.49e-05	0.000615	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—VAV1—brain cancer	3.46e-05	0.00061	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SUFU—brain cancer	3.37e-05	0.000594	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—IDH1—brain cancer	3.35e-05	0.000592	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.35e-05	0.000591	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—IL2—brain cancer	3.33e-05	0.000588	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.33e-05	0.000588	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.28e-05	0.00058	CbGpPWpGaD
Cimetidine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.27e-05	0.000577	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—GFAP—brain cancer	3.25e-05	0.000573	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.24e-05	0.000572	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.21e-05	0.000566	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—VAV1—brain cancer	3.14e-05	0.000554	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.14e-05	0.000554	CbGpPWpGaD
Cimetidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.14e-05	0.000554	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.09e-05	0.000545	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HEY1—brain cancer	3.08e-05	0.000544	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DLL1—brain cancer	3.02e-05	0.000533	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.01e-05	0.000532	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CYP2C9—brain cancer	3.01e-05	0.000531	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CYP2C9—brain cancer	3e-05	0.00053	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.94e-05	0.000519	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.87e-05	0.000507	CbGpPWpGaD
Cimetidine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.83e-05	0.0005	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CYP2C9—brain cancer	2.8e-05	0.000494	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—ENO2—brain cancer	2.77e-05	0.000488	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.76e-05	0.000487	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—PIK3CG—brain cancer	2.75e-05	0.000486	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.73e-05	0.000482	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—ENO2—brain cancer	2.65e-05	0.000468	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SHH—brain cancer	2.57e-05	0.000453	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—BSG—brain cancer	2.56e-05	0.000451	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—BSG—brain cancer	2.55e-05	0.00045	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.51e-05	0.000444	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.48e-05	0.000438	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TRPC6—brain cancer	2.48e-05	0.000437	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SMO—brain cancer	2.43e-05	0.00043	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTCH1—brain cancer	2.43e-05	0.00043	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—BSG—brain cancer	2.38e-05	0.00042	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.34e-05	0.000413	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—IDH1—brain cancer	2.2e-05	0.000388	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—PIK3CG—brain cancer	2.2e-05	0.000388	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—IDH1—brain cancer	2.19e-05	0.000387	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP2C9—brain cancer	2.18e-05	0.000384	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP2C9—brain cancer	2.17e-05	0.000384	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.15e-05	0.000379	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—IDH1—brain cancer	2.04e-05	0.000361	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—PIK3CG—brain cancer	1.99e-05	0.000352	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—PIK3CG—brain cancer	1.97e-05	0.000348	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.95e-05	0.000344	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NOTCH2—brain cancer	1.95e-05	0.000344	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP2C9—brain cancer	1.88e-05	0.000332	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VAV1—brain cancer	1.86e-05	0.000327	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—BSG—brain cancer	1.85e-05	0.000327	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—BSG—brain cancer	1.85e-05	0.000326	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.81e-05	0.00032	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ENO2—brain cancer	1.74e-05	0.000307	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ENO2—brain cancer	1.73e-05	0.000306	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP2C9—brain cancer	1.68e-05	0.000297	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP2C9—brain cancer	1.64e-05	0.000289	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PIK3CG—brain cancer	1.62e-05	0.000286	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ENO2—brain cancer	1.62e-05	0.000285	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.6e-05	0.000283	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—BSG—brain cancer	1.6e-05	0.000282	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HES1—brain cancer	1.6e-05	0.000282	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—IDH1—brain cancer	1.59e-05	0.000281	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—IDH1—brain cancer	1.59e-05	0.00028	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.59e-05	0.00028	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—IL2—brain cancer	1.55e-05	0.000273	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.54e-05	0.000273	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PDGFRA—brain cancer	1.52e-05	0.000268	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—SPP1—brain cancer	1.47e-05	0.00026	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—BSG—brain cancer	1.43e-05	0.000252	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL2—brain cancer	1.4e-05	0.000248	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.4e-05	0.000247	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—BSG—brain cancer	1.39e-05	0.000246	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—IDH1—brain cancer	1.38e-05	0.000243	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IRS2—brain cancer	1.33e-05	0.000235	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—BSG—brain cancer	1.31e-05	0.000232	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP2C9—brain cancer	1.31e-05	0.000231	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—BSG—brain cancer	1.3e-05	0.00023	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.29e-05	0.000227	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CG—brain cancer	1.27e-05	0.000224	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ENO2—brain cancer	1.26e-05	0.000222	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.26e-05	0.000222	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ENO2—brain cancer	1.26e-05	0.000222	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—IDH1—brain cancer	1.23e-05	0.000217	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CG—brain cancer	1.22e-05	0.000215	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—IDH1—brain cancer	1.2e-05	0.000212	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—APC—brain cancer	1.18e-05	0.000208	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CG—brain cancer	1.18e-05	0.000208	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—IDH1—brain cancer	1.13e-05	0.000199	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.12e-05	0.000198	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—IDH1—brain cancer	1.12e-05	0.000198	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—BSG—brain cancer	1.11e-05	0.000196	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ENO2—brain cancer	1.09e-05	0.000192	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—EGFR—brain cancer	1.07e-05	0.000189	CbGpPWpGaD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.06e-05	0.000186	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.01e-05	0.000178	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1e-05	0.000177	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ENO2—brain cancer	9.71e-06	0.000171	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—IDH1—brain cancer	9.57e-06	0.000169	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ENO2—brain cancer	9.47e-06	0.000167	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—RELA—brain cancer	9.2e-06	0.000162	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—ERBB2—brain cancer	9.15e-06	0.000161	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.12e-06	0.000161	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ENO2—brain cancer	8.93e-06	0.000158	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ENO2—brain cancer	8.85e-06	0.000156	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—BSG—brain cancer	8.59e-06	0.000152	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2—brain cancer	8.29e-06	0.000146	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—brain cancer	8.08e-06	0.000143	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CTNNB1—brain cancer	8e-06	0.000141	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CG—brain cancer	7.97e-06	0.000141	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CG—brain cancer	7.96e-06	0.00014	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.79e-06	0.000138	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ENO2—brain cancer	7.56e-06	0.000134	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CG—brain cancer	7.42e-06	0.000131	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—IDH1—brain cancer	7.38e-06	0.00013	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VEGFA—brain cancer	7.04e-06	0.000124	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STAT3—brain cancer	6.97e-06	0.000123	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MYC—brain cancer	6.48e-06	0.000114	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EGFR—brain cancer	6.34e-06	0.000112	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ENO2—brain cancer	5.84e-06	0.000103	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CG—brain cancer	5.77e-06	0.000102	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CG—brain cancer	5.76e-06	0.000102	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—brain cancer	5.32e-06	9.4e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CG—brain cancer	4.99e-06	8.81e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CG—brain cancer	4.45e-06	7.86e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CG—brain cancer	4.35e-06	7.67e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CG—brain cancer	4.1e-06	7.23e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.06e-06	7.17e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CG—brain cancer	3.47e-06	6.13e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.68e-06	4.73e-05	CbGpPWpGaD
